Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2287)
All Articles published online
|
Dec 14, 2007 (publication date) through Apr 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kwon HC, Oh SY, Lee S, Kim SH, Kim HJ. Bevacizumab plus infusional 5-fluorouracil, leucovorin and irinotecan for advanced colorectal cancer that progressed after oxaliplatin and irinotecan chemotherapy: A pilot study. World J Gastroenterol 2007; 13(46): 6231-6235 [PMID: 18069765 DOI: 10.3748/wjg.v13.i46.6231] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v13/i46/6231.htm |
| Number | Citing Articles |
| 1 |
Emmanuel Mitry, Astrid Lièvre, Jean-Baptiste Bachet, Philippe Rougier. Irinotecan as palliative chemotherapy for metastatic colorectal cancer: evolving tactics following initial treatment. International Journal of Colorectal Disease 2009; 24(6): 605 doi: 10.1007/s00384-009-0672-8
|
| 2 |
Gemma Palazzolo, Hilaria Mollica, Valeria Lusi, Mariangela Rutigliani, Martina Di Francesco, Rui Cruz Pereira, Marco Filauro, Laura Paleari, Andrea DeCensi, Paolo Decuzzi. Modulating the Distant Spreading of Patient-Derived Colorectal Cancer Cells via Aspirin and Metformin. Translational Oncology 2020; 13(4): 100760 doi: 10.1016/j.tranon.2020.100760
|
| 3 |
Osman Köstek, Muhammet Bekir Hacıoğlu, Abdullah Sakin, Tarık Demir, Murat Sarı, Ozlem Ozkul, Murat Araz, Aysun Fatma Doğan, Nazım Can Demircan, Sernaz Uzunoğlu, İrfan Çiçin, Bülent Erdoğan. Regorafenib or rechallenge chemotherapy: which is more effective in the third-line treatment of metastatic colorectal cancer?. Cancer Chemotherapy and Pharmacology 2019; 83(1): 115 doi: 10.1007/s00280-018-3713-6
|
| 4 |
Hui Wang, Jing Shi, Qin Wang, Hong Li, Kun Cai, Xiaojun Hou, Tao Li, Qi Zhong, Dechao Yu. Assessment of the pre-clinical immunogenicity of a new VEGF receptor Fc-fusion protein FP3 with ELISA and BIACORE. Cancer Immunology, Immunotherapy 2010; 59(2): 239 doi: 10.1007/s00262-009-0744-1
|
| 5 |
Moon Ki Choi, Yongjun Cha, Ji Yeon Baek. Retreatment of Irinotecan in Later Lines of Therapy for Metastatic Colorectal Cancer: A Retrospective Study. Oncology 2021; 99(10): 665 doi: 10.1159/000518041
|
| 6 |
Byung Woog Kang, Tae Won Kim, Jae-Lyun Lee, Min-Hee Ryu, Heung Moon Chang, Chang Sik Yu, Jin Cheon Kim, Jong Hoon Kim, Yoon-Koo Kang, Jung Shin Lee. Bevacizumab plus FOLFIRI or FOLFOX as third-line or later treatment in patients with metastatic colorectal cancer after failure of 5-fluorouracil, irinotecan, and oxaliplatin: a retrospective analysis. Medical Oncology 2009; 26(1): 32 doi: 10.1007/s12032-008-9077-8
|